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Edited by Maurice MontalAbstract Ca2+ inﬂux is known to be prerequisite for myoblast
fusion during skeletal muscle diﬀerentiation. Here, we show that
the N-methyl-D-aspartate (NMDA) receptor is involved in the
Ca2+ inﬂux of C2C12 myoblasts. NMDA receptor (NR) 1 and
NR2D were expressed in the myoblasts during muscle diﬀerenti-
ation. Using Ca2+ imaging analysis, Ca2+ inﬂux through NRs
was directly measured at a single-cell level. L-Glutamate in-
creased myoblast fusion as well as intracellular Ca2+ levels,
and both eﬀects were completely blocked by MK801, a selective
antagonist of NRs. Furthermore, treatment with the Ca2+ iono-
phore A23187 recovered MK801-mediated inhibition of myo-
blast fusion. These results suggest that the NRs may play an
important role in myoblast fusion by mediating Ca2+ inﬂux.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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A prominent event in skeletal muscle diﬀerentiation is the fu-
sion of mononucleated myoblasts into multinucleated myo-
tubes and this myogenic process absolutely requires Ca2+
inﬂux [1–3]. In addition, myoblast fusion is a fundamental
process for muscle growth and repair in adults. We have pre-
viously shown that nitric oxide acts as a messenger molecule
for myoblast fusion by mediating Ca2+-dependent increase in
intracellular cGMP level [4–6]. Unfortunately, the routes for
the entry of external Ca2+ into myoblasts are still being
debated.
Several diﬀerent types of Ca2+ permeable channels have been
proposed as mediators of Ca2+ inﬂux in myoblasts. Bernheim
and his colleagues have shown that T-type Ca2+ channels are
expressed in postnatal human myoblasts and may play a
crucial role in Ca2+ inﬂux triggering myoblast fusion in a volt-
age-dependent manner [7,8]. Despite these ﬁndings, voltage-
dependent calcium channels have not been detected in avian
and rodent myoblast cultures [9,10]. In this context, several
previous studies suggested alternative routes of Ca2+ inﬂux*Corresponding author. Fax: +82 2 884 6560.
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doi:10.1016/j.febslet.2004.10.076for myoblast fusion, such as stretch-activated cation channels
[10,11] or acetylcholine (ACh)-gated nicotinic channels [2,9].
These results give rise to two possibilities. One is that the
Ca2+ conducting mechanism required for myoblast fusion is
largely diﬀerent according to the species and the other is that
an increase in intracellular Ca2+ level large enough to trigger
myoblast fusion requires the concerted eﬀort of diﬀerent types
of channels which are permeable to Ca2+.
It is well established that glutamate serves as a neurotrans-
mitter at invertebrate neuromuscular junctions (NMJ) [12],
whereas ACh serves this role in vertebrates. In addition, sev-
eral studies in the last decade indicated a role for glutamate
as a signaling molecule at the vertebrate NMJs [13]. In rat
motoneuron terminals, glutamate-like immunoreactivity and
high levels of mRNA for a glutamate transporter are present
[14,15]. In addition, it was reported that N-acetylaspartylglut-
amate, its hydrolyzing enzyme N-acetylated a-linked acidic
dipeptidase (NAALADase), and NR1 are found in rat dia-
phragm NMJs, using immunochemistry techniques [16]. These
studies strongly suggest that N-methyl-D-aspartate (NMDA)
receptors are involved in skeletal muscle NMJs.
The NMDA receptor (NR) belongs to a family of receptor-
operated channels and is highly permeable to Ca2+ [17]. If this
receptor is found in the early stages of muscle diﬀerentiation, it
might function as a pathway for Ca2+ inﬂux in myoblasts
thereby triggering myoblast fusion. In this study, we sought
to identify the expression of NR subtypes and determine
whether Ca2+ inﬂux was mediated by these channels in
C2C12 myoblasts.2. Materials and methods
2.1. Materials
[a-32P]dCTP was purchased from DuPont NEN. NMDA, MK801,
and 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) were from Re-
search Biochemical Inc. Thapsigargin and calcium ionophore
(A23187) were from Sigma Chemical. Cell culture reagents were ob-
tained from Gibco Invitrogen.
2.2. Cell culture
C2C12 mouse skeletal muscle myoblasts were obtained from the
American Type Culture Collection (Rockville, MD). The cells were
cultured in growth medium (Dulbeccos modiﬁed Eagles medium,
DMEM) containing 10% fetal bovine serum and 1% penicillin–strepto-
mycin solution) at 37 C under 9% CO2. To induce diﬀerentiation from
myoblasts to myotubes, the medium was replaced at 48 h after plating
with a diﬀerentiation medium (DMEM containing 2% horse serum and
1% penicillin–streptomycin solution). When appropriate, drugs were
added when the medium was changed.ation of European Biochemical Societies.
Table 1
Primers used for RT-PCR
Gene Primer sequence Size (bp)
NR1 F: 5 0-AGTCCCTTTGGCCGATTTAA-30 459
R: 5 0-ACCAGATCGCACTTCTGTGA-30
NR2A F: 5 0-TGCA-AACATTTGTGGCCAAC-30 361
48 K.H. Lee et al. / FEBS Letters 578 (2004) 47–52For the measurement of myoblast fusion, cells were ﬁxed with 1%
(v/v) glutaraldehyde for 30 min, stained with 0.1% hematoxylin for
30 min, and observed under a microscope at a magniﬁcation of
200·. Myoblasts were considered fused and counted only if there
was clear cytoplasmic continuity and at least three nuclei were obvious.
Each data point represents the mean of counts from more than 30 ran-
domly chosen ﬁelds.R: 5 0-TTGGTCTTGTGGTTCTTATT-30
NR2B F: 5 0-AGCATCGGCATCGCTGTCAT-30 342
R: 5 0-GCCAAACTGGAAGAACATGG-30
NR2C F: 5 0-GGAGACACAG-AAGTTGGAGA-30 375
R: 5 0-ACGTCCTCTGTGCTCACCAT-30
NR2D F: 5 0-CGCCTCAAGTACCCTCTATG-30 333
R: 5 0-GACGCCATCG-ATCTTCTTGC-30
AMPA F: 5 0-CCTTTGGCCTATGAGATCTGGATGTG-3 0 749
R: 5 0-TCGTACCACCATTTGTTTTTCA-30
KA F: 5 0-TGGGCCTTCACCTTGATCATCA-30 512
R: 5 0-CTGTGGTCCTCCTCCTTGGG-302.3. Reverse transcription-polymerase chain reaction (RT-PCR)
RT-PCR was performed as described previously [18] with some
modiﬁcations. Brieﬂy, total RNA was extracted from C2C12 cells cul-
tured for 8 days using Trizol reagent (Life Technologies). One micro-
gram of the RNA templates was reverse-transcribed with SuperScript
II RT (Life Technologies) using the manufacturers instructions. Sub-
sequently, each RT sample was subjected to PCR (a total of 30 cycles)
using Taq polymerase (Perkin Elmer Cetus Corp., Norwalk, CT,
USA). PCR primers for each NR subunit and non-NMDA (AMPA
and KA) receptor subtype were chosen based on their sequence data
[19–22] and were described in Table 1. After PCR ampliﬁcation, the
products were electrophoresed on 2% agarose gels and stained with
ethidium bromide. All PCR products were cloned into pGEM-Teasy
vectors (Promega) and sequenced.
2.4. Northern blot analysis
Total RNA was isolated from cultured C2C12 muscle cells at vari-
ous time points using the Trizol reagent. The total RNA samples (30
lg each) were resolved on 1.2% formaldehyde agarose gels and trans-
ferred for 18 h by diﬀusion blotting to Nytran ﬁlters. 32P-labeled anti-
sense DNA probes to NR subunits were synthesized from linearized
plasmids containing each PCR product using Taq polymerase in the
presence of [a-32P]dCTP and each 3 0 primer. Hybridization procedures
were performed as previously described [23]. After hybridization,
membranes were exposed to X-ray ﬁlm at 70 C for 1–7 days. After
autoradiography, the membranes were stripped and rehybridized with
the control probes under the same conditions. Northern blot analyses
were repeated at least three times.
2.5. Patch-clamp recordings
Electrophysiological recordings were done in cultured C2C12 cells
using the whole-cell conﬁgurations of the patch-clamp technique.
The bath solution contained (in mM): NaCl 165, KCl 2.5, CaCl2 0.5,
glucose 10, HEPES 10, and glycine 0.001, pH adjusted to 7.4 with
NaOH. The pipette solution contained (in mM): CsF 130, CsCl 15,
CaCl2 0.5, EGTA 10, and HEPES 10, pH adjusted to 7.2 with CsOH.
Holding potential was 40 mV. Currents were recorded at room tem-
perature (20–23 C) using an Axopatch 200A ampliﬁer (Axon Instru-
ments). Drugs were dissolved in external solution and applied to
cells using a fast perfusion technique. A high-speed solution exchange
system (HSSE-2, Ala Scientiﬁc Instruments Inc.) was used for the ra-
pid application of glutamate. One mM glutamate was applied within
100 lm of the recorded cell allowing rapid application of drug.2.6. Ca2+ imaging
Cells were cultured on gelatin-coated glass coverslips for 2 days and
then loaded with 5 lM Fluo-3 AM (Molecular Probes, OR) by incuba-
tion for 60 min at room temperature in a normal bath solution [140
mM NaCl, 5.0 mM KCl, 2.5 mM CaCl2, 0.5 mM MgCl2, 10 mM glu-
cose, and 5.5 mM HEPES (pH 7.4)]. The Fluo-3 AM solution was re-
moved by rinsing twice with the normal bath solution, then kept in it
for 10 min at room temperature to complete ester-hydrolysis. To de-
plete stored intracellular Ca2+, the cells were preincubated in the nor-
mal bath solution containing 1 lM thapsigargin for 30 min prior to
experiments.
Intracellular Ca2+ concentrations were analyzed by the Fluo-3 AM
ﬂuorescence dye-detection method [24] using an inverted microscope
equipped for epi-ﬂuorescence and transmitted illumination (IX-70;
Olympus America, NY, USA). Fluorescent images were obtained
using a 40· objective lens; the excitation light source was a xenon lamp
coupled to excitation ﬁlter wheels. The emission ﬁlter wheel was cou-
pled to the microscope at the camera output port. Images were cap-
tured using a slow scan, liquid nitrogen-cooled, charge-coupled
device (CCD) camera with a back-thinned, back-illuminated imaging
chip (Quantix, Photometrics, AZ, USA). Optical excitation for Fluo-3 was accomplished with a 488 nm wavelength of xenon light. The
emitted ﬂuorescence was passed through a 535 nm emission ﬁlter be-
fore it reached the CCD camera. Fluorescent images were captured
in a slow mode (1 frame/5 s). An average brightness over time plot
was constructed for a deﬁned intracellular area with the plots corrected
for dye bleaching using an exponential decay algorithm (MetaFluor,
Universal Imaging, PA, USA). The data were presented as the average
of normalized ﬂuorescence ratio (F/F0) of 10 individual cells. All exper-
iments were repeated at least three times.
2.7. Statistical analysis
Statistical comparisons were analyzed by the unpaired Students t
test. A probability level of P < 0.05 was selected for determining statis-
tically signiﬁcant diﬀerences.3. Results
3.1. Presence of NR subtypes in C2C12 myogenic cells
It has been known that there are three distinct ionotropic
glutamate receptor subtypes in neuronal cells: NMDA, a-ami-
no-3-hydroxy-5-methyl-4-isoxazole (AMPA), and the kainite
(KA) receptor subtype [17]. To determine which types of gluta-
mate receptors are expressed in C2C12 myoblasts, RT-PCR
was performed using glutamate receptor subtype-speciﬁc
PCR primer sets (Table 1).
As shown in Fig. 1, both NMDA and non-NMDA (AMPA
and KA) receptors were expressed in C2C12 cells, although all
subunits of NR were not found. NRs consist of NR1 and
NR2A-2D subunits; the NR1 subunits are in hetero-oligo-
meric conﬁgurations with NR2A-2D [25]. NR1 and NR2D
were predominantly expressed, while NR2A was only slightly
expressed in C2C12 cells, whereas all types of NR2 subunits
were detected in the mouse whole brain, used as a positive con-
trol (Fig. 1A). These PCR products were sequenced and the re-
sults showed complete consensus with those previously
reported [19–22]. We then determined the expression pattern
of NR subunits during muscle diﬀerentiation using Northern
blots. The expression of the NR1 and NR2D subtypes gradu-
ally increased during diﬀerentiation (Fig. 1B); the NR2A sub-
type was not detected (data not shown).
3.2. Eﬀect of glutamate and NMDA on intracellular Ca2+ levels
in myoblasts
It is reasonable to assume that these NR subtypes are func-
tional and may be responsible for the Ca2+ inﬂux necessary for
myoblast fusion. To examine this possibility, we carried out
Glutamate
20 pA
4 sec
Fig. 2. Whole-cell recording of glutamate channels in C2C12. Appli-
cation of 1 mM glutamate produces an inward current response at 40
mV with transient components. For the rapid application, drug was
applied within 100 lm of the recorded cell using a high-speed solution
exchange system.
Fig. 1. Expression of ionotropic glutamate receptor subtypes in mouse
C2C12 cells. (A) RT-PCR product of NMDA subunits (upper and
middle panel) and non-NMDA subtypes (lower panel) from mouse
brain and C2C12 myoblasts. PCR was performed using speciﬁc
primers for NR subunits (NR1 and NR2A-2D) and non-NRs (AMPA
and KA). (B) Expression of NR subunits during skeletal muscle
diﬀerentiation. Total RNAs obtained from the cells cultured for the
indicated periods and subjected to Northern blots analysis using NR1,
NR2D, myosin heavy chain (MHC), and GAPDH probes. MHC and
GAPDH were shown as an indicator for myogenic diﬀerentiation and
the amount of the RNAs, respectively. Similar data were obtained in
three independent experiments.
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myoblasts. Treatment with L-glutamate induced an inward
current when the membrane potential was clamped at 40
mV (Fig. 2) and increased intracellular Ca2+ level in a dose-re-
lated manner and this eﬀect was maximal at 10 mM (Fig. 3A
and B). In addition, treatment with NMDA, a non-metabolic
agonist of NRs, showed similar increases in intracellular Ca2+
levels to glutamate at the same concentration (Fig. 3A and C).
These eﬀects might be due to external Ca2+, as pretreatment
with EGTA (2 mM) completely blocked the increase in intra-
cellular Ca2+ levels by glutamate (data not shown).
To further clarify the involvement of NRs in Ca2+ inﬂux of
C2C12 myoblasts, we depleted myoblast intracellular Ca2+
stores by preincubation with thapsigargin (1 lM), an inhibitor
of microsomal Ca2+-ATPase [26], for 30 min (Fig. 4A), and
examined the glutamate-induced increase in intracellular
Ca2+ levels with either antagonists of glutamate receptors or
not. Depletion of intracellular Ca2+ stores did not block the in-
crease in intracellular Ca2+ levels by L-glutamate (Fig. 4B); this
eﬀect was completely inhibited by 0.1 mM MK801, a selective
antagonist of NR (Fig. 4C). In contrast, 0.1 mM CNQX, a
non-NR inhibitor, did not aﬀect the glutamate-induced Ca2+
inﬂux (Fig. 4D). These results strongly suggest that Ca2+ inﬂux
could occur through NRs in C2C12 myoblasts.
3.3. Role of NRs on myoblast fusion
Ca2+ inﬂux is known to be essential for myoblast fusion [3].
In cultured myoblasts, intracellular Ca2+ levels were eﬀectively
increased by treatment with glutamate. Thus, we investigated
the role of NRs in myoblast fusion. C2C12 cells were treated
with increasing amounts of L-glutamate 2 days after plating
and assessed for the cell fusion 6 days later. As shown in
Fig. 5, glutamate promoted myoblast fusion dose-dependently,
as did NMDA (up to 5 mM) (data not shown), while MK801
dramatically inhibited spontaneous myoblast fusion as well as
the glutamate-induced myoblast fusion. Both eﬀects were dose-
dependent, and the eﬀect of glutamate was maximal at 10 mM,
the same concentration producing maximal intracellular Ca2+levels (Fig. 3). Upon treatment of myoblasts with MK801 at
all concentrations tested, there was no signiﬁcant eﬀect on cell
proliferation as assessed by [3H]thymidine incorporation (data
not shown). Moreover, MK801-mediated inhibition of sponta-
neous myoblast fusion was signiﬁcantly recovered by treat-
ment with Ca2+ ionophore A23187 (Fig. 5C). Thus, the eﬀect
by MK801 appears to be not due to simple cytotoxicity but
caused by inhibiting Ca2+ inﬂux through NRs.4. Discussion
There is considerable evidence that NRs mediate a fast exci-
tatory synapse transmission in the vertebrate central nervous
system (CNS) and are localized in both presynaptic and
postsynaptic neurons [17]. Although prior studies on this chan-
nel were usually focused on the CNS, some recent evidence
shows that functional NRs are not restricted to neurons but
are also expressed in several non-neuronal cells such as human
keratinocytes [27], rat pancreas [28,29], and cultured myocardi-
ocytes [27,28]. In the rat and mouse skeletal muscles, the NR
subunit R1 was found in NMJs [16,30]. It was also reported
that NR1 and the ACh receptor (AChR) were linked to nitric
oxide synthase 1 in C2C12 skeletal myotubes [31]. These re-
sults imply that functional NRs may exist in skeletal myotubes.
While NR1 was found in mature muscle [16,30,31], the
expression of NRs in myoblasts has not yet been determined.
The present study provides the ﬁrst evidence for NR subtype
expression in myoblasts and their involvement in muscle diﬀer-
entiation. C2C12 skeletal myotubes do express NR subtypes
such as NR1, NR2A, and NR2D. Also, glutamate and
NMDA increase Ca2+ levels in C2C12 myoblasts, implying
that NRs are one pathway for Ca2+ inﬂux, which is a prereq-
uisite for myoblast fusion.
It is of importance to determine whether motoneurons are
able to release glutamate as a neurotransmitter at NMJ. N-
Acetylaspartylglutamate, a dipeptide localized in putative
glutamatergic neurons in the brain, is found in mammalian
motoneurons [32]. This dipeptide is a partial agonist of
NRs in the brain [33] and can be cleaved into glutamate
and N-acetylasparate by the N-acetylated a-linked acidic dip-
eptidase (NAALADase) [34]. Since this dipeptide is also de-
tected at the NMJ [30], it is possible that glutamate might
be released by motoneurons and is thus involved in muscle
diﬀerentiation.
In the present study, we clearly show that the NR is a strong
candidate as a channel responsible for Ca2+ inﬂux in
Fig. 3. Eﬀect of glutamate and NMDA on intracellular Ca2+ levels in C2C12 myoblasts. Intracellular Ca2+ levels were monitored by Fluo-3
ﬂuorescence. The vertical axis represents relative ﬂuorescence intensity normalized to that of the basal level (F/F0). (A) Fluorescence images of Fluo-3
loaded cells during typical experiments. Images were presented at the indicated time, before (5 s) and after (40 s, 75 s) stimulation with glutamate or
NMDA (5 mM). Scale bar, 50 lm. (B) Changes in intracellular Ca2+ levels were monitored in the absence and presence of increasing amounts of
glutamate: 1 mM, green line; 5 mM, red line; 10 mM, blue line. (C) Changes in intracellular Ca2+ levels were monitored in the absence and presence of
increasing amounts of NMDA: 1 mM, green line; 5 mM, red line. All Ca2+ imaging analyses were repeated at least three times.
50 K.H. Lee et al. / FEBS Letters 578 (2004) 47–52myoblasts, thus playing a signiﬁcant role in triggering myo-
blast fusion. The overall mechanism of Ca2+ mobilization in
myoblasts is, however, still a matter of debate since various
types of Ca2+-permeable channels including T-type Ca2+ chan-BA
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Fig. 5. Eﬀects of glutamate and MK801 on myoblast fusion. C2C12
myoblasts were treated with the indicated amounts of the drugs 2 days
after plating; the extent of fusion was assessed at 8 days. Each bar
represents the mean SE of four independent cultures. (A) Eﬀect of
glutamate on myoblast fusion in the presence and absence of MK801.
*P < 0.05, **P < 0.01 vs. untreated group; P < 0.05, P < 0.01 vs. 10
mM glutamate-treated group. (B) Dose-dependent eﬀect of MK801 on
spontaneous myoblast fusion. *P < 0.05, **P < 0.01 vs. untreated
group. (C) Eﬀect of Ca2+ ionophore on reversal of MK801-mediated
inhibition of myoblast fusion. Cells cultured for 2 days were incubated
for 2 days in the presence or absence of 10 lM MK801. After the
incubation, they were treated with increasing amounts of Ca2+
ionophore (A23187) and cultured for 4 more days. *P < 0.05 vs. 10
lM MK801-treated group.
K.H. Lee et al. / FEBS Letters 578 (2004) 47–52 51but by a graded one and, therefore, any mechanism able to
modulate intracellular Ca2+ concentration could aﬀect the rate
of myoblast fusion [8]. All these ﬁndings increase the possibil-
ity that myoblast fusion might be triggered by the combined
eﬀect of Ca2+ inﬂuxes through diﬀerent types of Ca2+ permea-ble channels. In this regard, our present results are compati-
ble with previous ﬁndings and are suggestive of the fact that
Ca2+ inﬂux through NRs contribute, at least in part, to
increasing the intracellular Ca2+ concentration required to
trigger myoblast fusion.
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